Does Theravance Bio (TBPH) Have the Potential to Rally 30.64% as Wall Street Analysts Expect?

Shares of Theravance Biopharma (TBPH) have gained 25.8% over the past four weeks to close the last trading session at $18.7, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $24.43 indicates a potential upside of 30.6%.The mean estimate comprises seven short-term price targets with a standard deviation of $8.85. While the lowest estimate of $13.00 indicates a 30.5% decline from t ...